Nov 13, 2024 / 09:30AM GMT
Operator
Ladies and gentlemen, good day and welcome to SMS Pharmaceuticals Limited Q2 FY25 earnings conference call. This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions and expectations of the company as on date of this call.
These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.
Today we have with us Mr. Vamsi Krishna Potluri, Executive Director; Mr. Lakshmi Narayana Tammineedi, Chief Financial Officer and Mr. Thirumalesh Tumma, Company Secretary and Compliance Officer.
I now hand the conference over to Mr. Vamsi Krishna Potluri, Executive Director. Thank you and over to you, sir.
Vamsi Potluri - SMS Pharmaceuticals Ltd - Executive Director
Good afternoon and a warm welcome to you all for joining our Q2 FY25 earnings call. I hope everyone has had an opportunity to go through our financial results and investor presentation which has
Q2 2025 SMS Pharmaceuticals Ltd Earnings Call Transcript
Nov 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers